BlackRock Advisors’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-938,024
Closed -$199M 3767
2014
Q4
$199M Sell
938,024
-961,097
-51% -$191M 0.2% 123
2014
Q3
$338M Buy
1,899,121
+121,276
+7% +$20.1M 0.34% 71
2014
Q2
$301M Sell
1,777,845
-523,050
-23% -$81.4M 0.28% 82
2014
Q1
$286M Buy
2,300,895
+493,801
+27% +$60.1M 0.28% 85
2013
Q4
$201M Sell
1,807,094
-1,331,216
-42% -$127M 0.19% 132
2013
Q3
$284M Buy
3,138,310
+87,360
+3% +$7.84M 0.29% 93
2013
Q2
$257M Buy
+3,050,950
New +$317M 0.27% 94

Other funds holding AGN

BlackRock Advisors's AGN Position: Q1 2015 in Review

BlackRock Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 938,024 shares — an estimated $199M sold.

BlackRock Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $338M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • BlackRock Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • BlackRock Advisors sold 938,024 Allergan Inc shares in Q1 2015, an estimated $199M.
  • BlackRock Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • BlackRock Advisors's Allergan Inc position peaked at $338M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.